California State Teachers Retirement System grew its stake in Humana Inc (NYSE:HUM) by 5.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 261,949 shares of the insurance provider’s stock after purchasing an additional 14,201 shares during the quarter. California State Teachers Retirement System owned about 0.19% of Humana worth $64,982,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of HUM. Janus Henderson Group PLC lifted its stake in shares of Humana by 74.1% in the 3rd quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock valued at $664,921,000 after purchasing an additional 1,161,661 shares during the period. APG Asset Management N.V. lifted its stake in shares of Humana by 60.3% in the 4th quarter. APG Asset Management N.V. now owns 729,519 shares of the insurance provider’s stock valued at $150,709,000 after purchasing an additional 274,435 shares during the period. Bank of Montreal Can lifted its stake in shares of Humana by 118.3% in the 4th quarter. Bank of Montreal Can now owns 501,379 shares of the insurance provider’s stock valued at $124,378,000 after purchasing an additional 271,701 shares during the period. Virtus Fund Advisers LLC lifted its stake in shares of Humana by 116.8% in the 4th quarter. Virtus Fund Advisers LLC now owns 423,275 shares of the insurance provider’s stock valued at $105,171,000 after purchasing an additional 228,050 shares during the period. Finally, Hudson Bay Capital Management LP lifted its stake in shares of Humana by 785.6% in the 4th quarter. Hudson Bay Capital Management LP now owns 221,398 shares of the insurance provider’s stock valued at $54,922,000 after purchasing an additional 196,398 shares during the period. 97.85% of the stock is currently owned by institutional investors.
A number of research firms have recently weighed in on HUM. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a research note on Tuesday. JPMorgan Chase & Co. increased their price target on Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a research note on Monday, February 12th. Oppenheimer increased their price target on Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a research note on Thursday, February 8th. Cantor Fitzgerald reissued a “hold” rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, February 7th. Finally, Leerink Swann increased their price target on Humana from $280.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, February 8th. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Humana has an average rating of “Buy” and a consensus price target of $270.47.
Humana (NYSE:HUM) last released its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.00 by $0.06. The firm had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The company’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.34 EPS. equities analysts forecast that Humana Inc will post 13.81 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Wednesday, March 28th. This is a boost from Humana’s previous quarterly dividend of $0.40. Humana’s dividend payout ratio is 9.09%.
Humana declared that its board has initiated a share buyback program on Thursday, December 14th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the insurance provider to reacquire shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its shares are undervalued.
In other Humana news, CEO Bruce D. Broussard sold 14,075 shares of the stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $274.32, for a total transaction of $3,861,054.00. Following the completion of the transaction, the chief executive officer now owns 113,896 shares in the company, valued at approximately $31,243,950.72. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Cynthia H. Zipperle sold 1,196 shares of the stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $273.33, for a total value of $326,902.68. Following the transaction, the senior vice president now owns 7,771 shares of the company’s stock, valued at approximately $2,124,047.43. The disclosure for this sale can be found here. In the last quarter, insiders have sold 41,775 shares of company stock valued at $11,169,845. Corporate insiders own 0.60% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “California State Teachers Retirement System Has $64.98 Million Stake in Humana Inc (HUM)” was posted by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/03/14/california-state-teachers-retirement-system-has-64-98-million-stake-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.